| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SYKStryker Corporation | 138.62B | 362.49 | 46.71 | 10.23% | 12.07% | 13.51% | 2.52% | 0.68 |
| SNNSmith & Nephew plc | 13.96B | 32.89 | 34.99 | 4.7% | 6.88% | 14.44% | 4.34% | 0.63 |
| ZBHZimmer Biomet Holdings, Inc. | 17.59B | 88.75 | 20.03 | 3.85% | 10.05% | 6.31% | 6.5% | 0.50 |
| CNMDCONMED Corporation | 1.32B | 42.55 | 9.99 | 5% | 4.75% | 6.35% | 11.68% | 0.94 |
| DHAIDIH Holding US, Inc. | 6.7K | 0.00 | -0.00 | -2.5% | -13.8% | |||
| LFWDLifeward Ltd. | 13.23M | 0.72 | -0.22 | 85.24% | -121.82% | -233.98% | 0.05 | |
| ANIKAnika Therapeutics, Inc. | 137.43M | 9.53 | -2.49 | -0.73% | -40.83% | -22.5% | 0.17 | |
| SNWVSANUWAVE Health, Inc. | 237.99M | 27.75 | -3.95 | 59.99% | -17.06% | 0.83% |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 31M | 37.3M | 45.62M | 57.56M | 72.55M | 71.08M | 98.05M | 122.29M | 148.73M | 204.73M |
| Revenue Growth % | 0.31% | 0.2% | 0.22% | 0.26% | 0.26% | -0.02% | 0.38% | 0.25% | 0.22% | 0.38% |
| Cost of Goods Sold | 9.37M | 10.93M | 11.17M | 14.88M | 17.93M | 16.05M | 24.65M | 31.63M | 37.48M | 56.13M |
| COGS % of Revenue | 0.3% | 0.29% | 0.24% | 0.26% | 0.25% | 0.23% | 0.25% | 0.26% | 0.25% | 0.27% |
| Gross Profit | 21.64M | 26.37M | 34.45M | 42.68M | 54.62M | 55.03M | 73.4M | 90.66M | 111.25M | 148.6M |
| Gross Margin % | 0.7% | 0.71% | 0.76% | 0.74% | 0.75% | 0.77% | 0.75% | 0.74% | 0.75% | 0.73% |
| Gross Profit Growth % | 0.3% | 0.22% | 0.31% | 0.24% | 0.28% | 0.01% | 0.33% | 0.24% | 0.23% | 0.34% |
| Operating Expenses | 28.23M | 32.49M | 40.92M | 52.23M | 63.7M | 81.79M | 91.43M | 116.06M | 138M | 178.12M |
| OpEx % of Revenue | 0.91% | 0.87% | 0.9% | 0.91% | 0.88% | 1.15% | 0.93% | 0.95% | 0.93% | 0.87% |
| Selling, General & Admin | 26.44M | 30.27M | 37.5M | 47.5M | 57.95M | 70.17M | 85.73M | 104M | 126.12M | 167.09M |
| SG&A % of Revenue | 0.85% | 0.81% | 0.82% | 0.83% | 0.8% | 0.99% | 0.87% | 0.85% | 0.85% | 0.82% |
| Research & Development | 1.79M | 2.22M | 3.42M | 4.73M | 5.75M | 5.27M | 5.54M | 8.45M | 10.89M | 11.03M |
| R&D % of Revenue | 0.06% | 0.06% | 0.08% | 0.08% | 0.08% | 0.07% | 0.06% | 0.07% | 0.07% | 0.05% |
| Other Operating Expenses | -31K | 0 | 30K | -217K | 0 | 6.34M | 150K | 3.61M | 985K | 0 |
| Operating Income | -6.59M | -6.13M | -6.47M | -9.55M | -9.08M | -26.75M | -18.02M | -25.4M | -26.75M | -29.52M |
| Operating Margin % | -0.21% | -0.16% | -0.14% | -0.17% | -0.13% | -0.38% | -0.18% | -0.21% | -0.18% | -0.14% |
| Operating Income Growth % | 0.08% | 0.07% | -0.06% | -0.48% | 0.05% | -1.95% | 0.33% | -0.41% | -0.05% | -0.1% |
| EBITDA | -4.74M | -4.22M | -4.07M | -6.66M | -4.44M | -18.75M | -7.34M | -12.3M | -9.37M | -10.44M |
| EBITDA Margin % | -0.15% | -0.11% | -0.09% | -0.12% | -0.06% | -0.26% | -0.07% | -0.1% | -0.06% | -0.05% |
| EBITDA Growth % | 0.15% | 0.11% | 0.04% | -0.64% | 0.33% | -3.22% | 0.61% | -0.67% | 0.24% | -0.11% |
| D&A (Non-Cash Add-back) | 1.85M | 1.9M | 2.4M | 2.89M | 4.64M | 8.01M | 10.68M | 13.1M | 17.39M | 19.08M |
| EBIT | -6.62M | -5.1M | -6.44M | -9.77M | -9.15M | -30.25M | -17.87M | -21.79M | -25.77M | -29.52M |
| Net Interest Income | -1.23M | -1.48M | -2.49M | -2.25M | -3.54M | -3.41M | -2.25M | -2.42M | 198K | -2.62M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 198K | 0 |
| Interest Expense | 1.23M | 1.48M | 2.49M | 2.25M | 3.54M | 3.41M | 2.25M | 2.42M | 0 | 2.62M |
| Other Income/Expense | -1.26M | -445K | -2.46M | -2.47M | -3.61M | -6.91M | 636K | 21.71M | 5.44M | -12.41M |
| Pretax Income | -7.85M | -6.57M | -8.93M | -12.03M | -12.69M | -33.67M | -17.39M | -3.69M | -21.31M | -41.93M |
| Pretax Margin % | -0.25% | -0.18% | -0.2% | -0.21% | -0.17% | -0.47% | -0.18% | -0.03% | -0.14% | -0.2% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | -723K | -1.13M | -4.95M | -338K | -4.11M |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1.08% | 0.98% | 0.94% | -0.34% | 0.98% | 0.9% |
| Net Income | -7.89M | -6.57M | -8.93M | -12.03M | -13.73M | -32.94M | -16.26M | 1.26M | -20.97M | -37.82M |
| Net Margin % | -0.25% | -0.18% | -0.2% | -0.21% | -0.19% | -0.46% | -0.17% | 0.01% | -0.14% | -0.18% |
| Net Income Growth % | 0.17% | 0.17% | -0.36% | -0.35% | -0.14% | -1.4% | 0.51% | 1.08% | -17.67% | -0.8% |
| Net Income (Continuing) | -7.85M | -6.57M | -8.93M | -12.03M | -12.69M | -32.94M | -16.26M | 1.26M | -20.97M | -37.82M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.05 | -0.87 | -1.85 | -0.96 | -1.18 | -1.82 | -0.84 | 0.06 | -0.92 | -1.64 |
| EPS Growth % | 0.18% | 0.17% | -1.13% | 0.48% | -0.23% | -0.54% | 0.54% | 1.07% | -16.59% | -0.78% |
| EPS (Basic) | -1.05 | -0.87 | -1.85 | -0.96 | -1.18 | -1.82 | -0.84 | 0.06 | -0.92 | -1.64 |
| Diluted Shares Outstanding | 7.51M | 7.51M | 4.82M | 12.57M | 14.62M | 18.06M | 19.27M | 20.95M | 22.68M | 23.08M |
| Basic Shares Outstanding | 7.51M | 7.51M | 4.82M | 12.57M | 14.62M | 18.06M | 19.27M | 20.7M | 22.68M | 23.08M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 22.47M | 20.83M | 69.56M | 97.16M | 128.06M | 158.43M | 133.65M | 226.72M | 226.5M | 237.17M |
| Cash & Short-Term Investments | 3.88M | 1.61M | 42.58M | 60.69M | 70.78M | 85.27M | 54.91M | 118.29M | 80.31M | 68.83M |
| Cash Only | 3.88M | 1.61M | 42.58M | 60.69M | 70.78M | 30.13M | 9.01M | 8.99M | 31.05M | 43.82M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 55.14M | 45.9M | 109.3M | 49.25M | 25.01M |
| Accounts Receivable | 3.82M | 4.1M | 5.6M | 9.5M | 16.57M | 17.55M | 17.94M | 24.8M | 34.62M | 42.36M |
| Days Sales Outstanding | 44.95 | 40.1 | 44.83 | 60.25 | 83.35 | 90.12 | 66.79 | 74.02 | 84.95 | 75.52 |
| Inventory | 14.55M | 14.89M | 20.55M | 25.71M | 38M | 52.99M | 57.57M | 78.19M | 105.85M | 117M |
| Days Inventory Outstanding | 566.96 | 497.06 | 671.35 | 630.65 | 773.43 | 1.21K | 852.58 | 902.34 | 1.03K | 760.87 |
| Other Current Assets | 0 | 233K | 831K | 0 | 1.25M | 2.62M | 3.23M | 1.47M | 5.72M | 1.96M |
| Total Non-Current Assets | 8.22M | 9.85M | 12.74M | 14.95M | 66.51M | 166.4M | 174.75M | 201.01M | 212.25M | 236.04M |
| Property, Plant & Equipment | 7.34M | 8.59M | 10.39M | 12.77M | 21.35M | 27.23M | 28.52M | 34.29M | 41.05M | 58.83M |
| Fixed Asset Turnover | 4.23x | 4.34x | 4.39x | 4.51x | 3.40x | 2.61x | 3.44x | 3.57x | 3.62x | 3.48x |
| Goodwill | 0 | 0 | 0 | 0 | 26.18M | 70.51M | 72.35M | 86.82M | 83.7M | 93.84M |
| Intangible Assets | 887K | 1.26M | 2.35M | 2.18M | 18.97M | 64.25M | 69.76M | 79.9M | 84.56M | 81.18M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 53.26M | 0 | 0 | 189.52M | 1.85M | 2.18M |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | -54.1M | 0 | 0 | -195.48M | 1.08M | 0 |
| Total Assets | 30.69M | 30.68M | 82.3M | 112.11M | 194.56M | 324.83M | 308.4M | 427.73M | 438.75M | 473.21M |
| Asset Turnover | 1.01x | 1.22x | 0.55x | 0.51x | 0.37x | 0.22x | 0.32x | 0.29x | 0.34x | 0.43x |
| Asset Growth % | -0.14% | -0% | 1.68% | 0.36% | 0.74% | 0.67% | -0.05% | 0.39% | 0.03% | 0.08% |
| Total Current Liabilities | 6.34M | 7.25M | 9.47M | 9.22M | 13.66M | 35.03M | 29.71M | 30.87M | 41.67M | 33.96M |
| Accounts Payable | 2M | 3.54M | 5.5M | 3.97M | 6.47M | 10.04M | 9.32M | 11.15M | 12.65M | 8.91M |
| Days Payables Outstanding | 77.89 | 118.31 | 179.56 | 97.41 | 131.63 | 228.32 | 138.1 | 128.67 | 123.19 | 57.93 |
| Short-Term Debt | 101K | 107K | 113K | 118K | 124K | 12.36M | 13M | 144K | 152K | 160K |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 1000K | 0 | 0 |
| Other Current Liabilities | 1.98M | 1.38M | 954K | 1.58M | -1.63M | 8.09M | 2.04M | 6.88M | 7.39M | 8.89M |
| Current Ratio | 3.55x | 2.87x | 7.35x | 10.54x | 9.37x | 4.52x | 4.50x | 7.34x | 5.44x | 6.98x |
| Quick Ratio | 1.25x | 0.82x | 5.18x | 7.75x | 6.59x | 3.01x | 2.56x | 4.81x | 2.90x | 3.54x |
| Cash Conversion Cycle | 534.02 | 418.86 | 536.61 | 593.48 | 725.15 | 1.07K | 781.27 | 847.69 | 992.63 | 778.46 |
| Total Non-Current Liabilities | 13.04M | 17.43M | 25.34M | 21.16M | 38.54M | 55.03M | 53.32M | 18.21M | 20.05M | 84.68M |
| Long-Term Debt | 13.04M | 17.43M | 25.34M | 21.16M | 26.07M | 13.83M | 15.22M | 763K | 9.91M | 72.96M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 63K | 323K | 293K | 0 | 0 | 5.66M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | -63K | 10.17M | 8.9M | 5.95M | 5.48M | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 30.71M | 28.91M | 11.49M | 4.66M | 6.06M |
| Total Liabilities | 19.38M | 24.68M | 34.81M | 30.37M | 52.2M | 90.06M | 83.03M | 49.08M | 61.72M | 118.64M |
| Total Debt | 13.14M | 17.54M | 25.45M | 21.27M | 26.25M | 26.52M | 28.51M | 907K | 10.06M | 80.9M |
| Net Debt | 9.26M | 15.93M | -17.13M | -39.42M | -44.52M | -3.62M | 19.5M | -8.08M | -21M | 37.08M |
| Debt / Equity | 1.16x | 2.93x | 0.54x | 0.26x | 0.18x | 0.11x | 0.13x | 0.00x | 0.03x | 0.23x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -5.36x | -4.15x | -2.60x | -4.24x | -2.57x | -7.84x | -8.02x | -10.48x | - | -11.26x |
| Total Equity | 11.31M | 5.99M | 47.49M | 81.73M | 142.36M | 234.77M | 225.37M | 378.65M | 377.02M | 354.57M |
| Equity Growth % | -0.37% | -0.47% | 6.92% | 0.72% | 0.74% | 0.65% | -0.04% | 0.68% | -0% | -0.06% |
| Book Value per Share | 1.51 | 0.80 | 9.86 | 6.50 | 9.73 | 13.00 | 11.70 | 18.08 | 16.63 | 15.36 |
| Total Shareholders' Equity | 11.31M | 5.99M | 47.49M | 81.73M | 142.36M | 234.77M | 225.37M | 378.65M | 377.02M | 354.57M |
| Common Stock | 1K | 1K | 2K | 4K | 4K | 5K | 5K | 6K | 6K | 6K |
| Retained Earnings | -71.56M | -78.13M | -103.07M | -115.09M | -128.82M | -161.77M | -178.03M | -176.77M | -197.74M | -235.56M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -6.24M | 0 | 135K | -623K | -3K | 7.91M | 8.49M | -5.4M | -5.53M | -10.77M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -892K | -1.12M | -7.22M | -15.58M | -17.77M | -18.53M | -13.06M | -21.77M | -27.05M | -27.05M |
| Operating CF Margin % | -0.03% | -0.03% | -0.16% | -0.27% | -0.24% | -0.26% | -0.13% | -0.18% | -0.18% | -0.13% |
| Operating CF Growth % | 0.91% | -0.25% | -5.45% | -1.16% | -0.14% | -0.04% | 0.3% | -0.67% | -0.24% | -0% |
| Net Income | -7.89M | -6.57M | -8.93M | -12.03M | -13.73M | -32.94M | -16.26M | 1.26M | -20.97M | -37.82M |
| Depreciation & Amortization | 1.85M | 1.9M | 2.4M | 2.89M | 4.67M | 8.01M | 10.68M | 13.1M | 17.39M | 19.08M |
| Stock-Based Compensation | 1.23M | 1.25M | 3.48M | 3.19M | 2.6M | 6.2M | 5.84M | 6.68M | 10.53M | 13.55M |
| Deferred Taxes | -1.19M | 0 | 0 | 0 | -144K | -723K | -1.13M | -5.03M | -1.16M | -4.74M |
| Other Non-Cash Items | 1.23M | -889K | 12.25M | 19.09M | 210K | 5.92M | 354K | -20.01M | -623K | 5.82M |
| Working Capital Changes | 3.88M | 3.19M | -4.17M | -9.63M | -11.38M | -4.99M | -12.55M | -17.76M | -32.2M | -22.93M |
| Change in Receivables | -1.05M | -280K | -1.5M | -3.8M | -5.82M | -451K | -466K | -3.98M | -9.72M | -4.75M |
| Change in Inventory | 3.27M | 889K | -4.41M | -4.8M | -9.77M | -12.07M | -5.05M | -16.94M | -26.28M | -13.2M |
| Change in Payables | 1.35M | 1.54M | 1.95M | -1.52M | 2.4M | 3.07M | -567K | -209K | 1.49M | -4.28M |
| Cash from Investing | -1.71M | -4.75M | -6.54M | -5.96M | -61.92M | -69.69M | -7.41M | -113.37M | 41.68M | -13.16M |
| Capital Expenditures | -2.25M | -4.75M | -6.54M | -5.46M | -12.09M | -11.3M | -16.01M | -10.03M | -16.88M | -14.26M |
| CapEx % of Revenue | 0.07% | 0.13% | 0.14% | 0.09% | 0.17% | 0.16% | 0.16% | 0.08% | 0.11% | 0.07% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 539K | -406K | -1.34M | -502K | 0 | -796K | -650K | 0 | -2.11M | -2.88M |
| Cash from Financing | -98K | 3.6M | 54.73M | 39.66M | 91.02M | 46.73M | 6K | 135.97M | 7.3M | 53.13M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | -5.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | -794K | 0 | 410K | 1.14M | 1.65M | 0 | -3.17M | -2M | -3.41M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -3.14M | -5.87M | -13.76M | -21.05M | -29.86M | -29.83M | -29.07M | -31.8M | -46.03M | -41.31M |
| FCF Margin % | -0.1% | -0.16% | -0.3% | -0.37% | -0.41% | -0.42% | -0.3% | -0.26% | -0.31% | -0.2% |
| FCF Growth % | 0.76% | -0.87% | -1.34% | -0.53% | -0.42% | 0% | 0.03% | -0.09% | -0.45% | 0.1% |
| FCF per Share | -0.42 | -0.78 | -2.86 | -1.67 | -2.04 | -1.65 | -1.51 | -1.52 | -2.03 | -1.79 |
| FCF Conversion (FCF/Net Income) | 0.11x | 0.17x | 0.81x | 1.30x | 1.29x | 0.56x | 0.80x | -17.30x | 1.29x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -53.88% | -75.94% | -33.4% | -18.61% | -12.25% | -17.47% | -7.07% | 0.42% | -5.55% | -10.34% |
| Return on Invested Capital (ROIC) | -21.87% | -21.62% | -18.57% | -19.72% | -9.71% | -12.2% | -5.68% | -6.19% | -5.52% | -5.92% |
| Gross Margin | 69.79% | 70.69% | 75.52% | 74.15% | 75.28% | 77.42% | 74.86% | 74.14% | 74.8% | 72.58% |
| Net Margin | -25.45% | -17.62% | -19.58% | -20.89% | -18.93% | -46.35% | -16.58% | 1.03% | -14.1% | -18.47% |
| Debt / Equity | 1.16x | 2.93x | 0.54x | 0.26x | 0.18x | 0.11x | 0.13x | 0.00x | 0.03x | 0.23x |
| Interest Coverage | -5.36x | -4.15x | -2.60x | -4.24x | -2.57x | -7.84x | -8.02x | -10.48x | - | -11.26x |
| FCF Conversion | 0.11x | 0.17x | 0.81x | 1.30x | 1.29x | 0.56x | 0.80x | -17.30x | 1.29x | 0.72x |
| Revenue Growth | 30.91% | 20.3% | 22.31% | 26.17% | 26.05% | -2.03% | 37.95% | 24.72% | 21.62% | 37.65% |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Trauma and Deformity | 32.8M | 39.7M | 49.37M | 47.68M | 65.83M | 85.06M | 106.78M | 145.13M |
| Trauma and Deformity Growth | - | 21.02% | 24.38% | -3.43% | 38.07% | 29.21% | 25.54% | 35.91% |
| Spine | 11.59M | 16.66M | 21.48M | 20.74M | 28.05M | 33.43M | 37.93M | 55.15M |
| Spine Growth | - | 43.82% | 28.95% | -3.48% | 35.24% | 19.19% | 13.48% | 45.40% |
| ACL Reconstruction and Other | 1.23M | 1.2M | 1.7M | 2.66M | 4.17M | 3.81M | 4.02M | 4.45M |
| ACL Reconstruction and Other Growth | - | -2.59% | 41.10% | 57.02% | 56.74% | -8.82% | 5.57% | 10.70% |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| UNITED STATES | 34.91M | 43.46M | 55.05M | 62.97M | 77.78M | 92.42M | 111.01M | 161.16M |
| UNITED STATES Growth | - | 24.50% | 26.68% | 14.37% | 23.53% | 18.82% | 20.12% | 45.18% |
| Non-US | - | 14.1M | 17.5M | 8.11M | 20.27M | 29.87M | 37.72M | 43.56M |
| Non-US Growth | - | - | 24.11% | -53.64% | 149.85% | 47.38% | 26.29% | 15.49% |
OrthoPediatrics Corp. (KIDS) reported $227.4M in revenue for fiscal year 2024. This represents a 860% increase from $23.7M in 2014.
OrthoPediatrics Corp. (KIDS) grew revenue by 37.6% over the past year. This is strong growth.
OrthoPediatrics Corp. (KIDS) reported a net loss of $45.6M for fiscal year 2024.
OrthoPediatrics Corp. (KIDS) has a return on equity (ROE) of -10.3%. Negative ROE indicates the company is unprofitable.
OrthoPediatrics Corp. (KIDS) had negative free cash flow of $29.4M in fiscal year 2024, likely due to heavy capital investments.